AMERI Holdings, Inc. (NASDAQ:AMRH) ("Ameri", the "Company"), announced that the Securities and Exchange Commission ("SEC") has declared the Registration Statement on Form S-4 in connection with the Company's proposed tender agreement with Jay Pharma to be effective.
The Company has set Wednesday, December 23, 2020 for a special meeting for its stockholders to approve the proposals associated with the merger. The Proxy Statement to its stockholders is available at: www.ameri100.com/for-investors/.
The Boards of Directors of both companies are excited to be entering the final step prior to a successful conclusion of the long-awaited reverse merger transaction.
The S-4 and other Ameri Holdings' SEC filings are available at: https://ameri100.com/for-investors/sec-filing/.
Ameri's common stock is currently traded on Nasdaq under the symbol "AMRH." Completion of the transaction is subject to approval by Ameri and Jay Pharma stockholders, Nasdaq approval, and other customary closing conditions.